
Methylcobalamin (1500mcg) + Pregabalin (75mg)
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
The Nervijen-P SR Tablet is a pharmaceutical formulation designed for the management of neuropathic pain and vitamin B12 deficiency. Each tablet contains Methylcobalamin, a bioavailable form of vitamin B12 (1500mcg), and Pregabalin, an anticonvulsant and neuroleptic agent (75mg). This combined therapy aims to alleviate neuropathic pain while addressing potential vitamin B12 deficiencies that may coexist. As with any medication, it should be used under medical supervision, and potential interactions with other medications should be discussed with a healthcare provider. The extended-release (SR) format allows for a steady release of the active ingredients over an extended period, providing optimal therapeutic efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nervijen-P SR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nervijen-P SR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nervijen-P SR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nervijen-P SR Tablet may be needed. Please consult your doctor.
Exercise Caution
Nervijen-P SR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nervijen-P SR Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nervijen-P SR Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nervijen-P SR Tablet

Methylcobalamin (1500mcg) + Pregabalin (75mg)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Methylcobalamin acts as a cofactor in the synthesis of methionine from homocysteine, promoting nerve health and red blood cell formation.
Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels, inhibiting excitatory neurotransmitter release and reducing neuronal excitability.
Medical applications
The Nervijen-P SR Tablet is a pharmaceutical formulation designed for the management of neuropathic pain and vitamin B12 deficiency. Each tablet contains Methylcobalamin, a bioavailable form of vitamin B12 (1500mcg), and Pregabalin, an anticonvulsant and neuroleptic agent (75mg). This combined therapy aims to alleviate neuropathic pain while addressing potential vitamin B12 deficiencies that may coexist. As with any medication, it should be used under medical supervision, and potential interactions with other medications should be discussed with a healthcare provider. The extended-release (SR) format allows for a steady release of the active ingredients over an extended period, providing optimal therapeutic efficacy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Nervijen-P SR Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Nervijen-P SR Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Nervijen-P SR Tablet should be used with caution in patients with kidney disease. Dose adjustment of Nervijen-P SR Tablet may be needed. Please consult your doctor.
Exercise Caution
Nervijen-P SR Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Nervijen-P SR Tablet is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Nervijen-P SR Tablet may not be needed in these patients. Please consult your doctor.
Regular Checkup
0 reviews for Nervijen-P SR Tablet















